BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 15076812)

  • 41. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality.
    Chaudhry S; Jin L; Meltzer D
    Med Care; 2005 Jun; 43(6):607-15. PubMed ID: 15908856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictability of claim-data-based comorbidity-adjusted models could be improved by using medication data.
    Bang JH; Hwang SH; Lee EJ; Kim Y
    BMC Med Inform Decis Mak; 2013 Nov; 13():128. PubMed ID: 24257030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining Charlson and Elixhauser scores with varying lookback predicated mortality better than using individual scores.
    Pritchard E; Fawcett N; Quan TP; Crook D; Peto TE; Walker AS
    J Clin Epidemiol; 2021 Feb; 130():32-41. PubMed ID: 33002637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM-Coded Data Among Older Adults.
    Mehta HB; Li S; An H; Goodwin JS; Alexander GC; Segal JB
    Ann Intern Med; 2022 Oct; 175(10):1423-1430. PubMed ID: 36095314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validity of information on comorbidity derived rom ICD-9-CCM administrative data.
    Quan H; Parsons GA; Ghali WA
    Med Care; 2002 Aug; 40(8):675-85. PubMed ID: 12187181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of an epilepsy-specific risk adjustment comorbidity index.
    St Germaine-Smith C; Liu M; Quan H; Wiebe S; Jette N
    Epilepsia; 2011 Dec; 52(12):2161-7. PubMed ID: 22004000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combining the Hospital Frailty Risk Score With the Charlson and Elixhauser Multimorbidity Indices to Identify Older Patients at Risk of Poor Outcomes in Acute Care.
    Gilbert T; Cordier Q; Polazzi S; Street A; Conroy S; Duclos A
    Med Care; 2024 Feb; 62(2):117-124. PubMed ID: 38079225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods.
    Myers RP; Quan H; Hubbard JN; Shaheen AA; Kaplan GG
    Hepatology; 2009 Feb; 49(2):568-77. PubMed ID: 19085957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review of comorbidity indices for administrative data.
    Sharabiani MT; Aylin P; Bottle A
    Med Care; 2012 Dec; 50(12):1109-18. PubMed ID: 22929993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving Risk Adjustment Above Current Centers for Disease Control and Prevention Methodology Using Electronically Available Comorbid Conditions.
    Jackson SS; Leekha S; Pineles L; Magder LS; Thom KA; Wang Y; Harris AD
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1173-8. PubMed ID: 27418295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices.
    Prommik P; Tootsi K; Saluse T; Strauss E; Kolk H; Märtson A
    BMC Med Res Methodol; 2022 Jan; 22(1):4. PubMed ID: 34996364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality.
    Ward MM
    J Rheumatol; 2000 Jun; 27(6):1408-13. PubMed ID: 10852262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive performance of comorbidity measures in administrative databases for diabetes cohorts.
    Lix LM; Quail J; Fadahunsi O; Teare GF
    BMC Health Serv Res; 2013 Aug; 13():340. PubMed ID: 24059446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of seven comorbidity scores on four-month survival of lung cancer patients.
    Pluchart H; Bailly S; Chanoine S; Moro-Sibilot D; Bedouch P; Toffart AC
    BMC Med Res Methodol; 2023 Nov; 23(1):256. PubMed ID: 37923993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing the Performance of Charlson and Elixhauser Comorbidity Indices to Predict In-Hospital Mortality Among a Chinese Population.
    Cai M; Liu E; Zhang R; Lin X; Rigdon SE; Qian Z; Belue R; Chang JJ
    Clin Epidemiol; 2020; 12():307-316. PubMed ID: 32256119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of risk adjustment methods in patients with liver disease using electronic medical record data.
    Xu Y; Li N; Lu M; Dixon E; Myers RP; Jolley RJ; Quan H
    BMC Gastroenterol; 2017 Jan; 17(1):5. PubMed ID: 28061757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data.
    Ghali WA; Hall RE; Rosen AK; Ash AS; Moskowitz MA
    J Clin Epidemiol; 1996 Mar; 49(3):273-8. PubMed ID: 8676173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the Value of Comorbidity Indices for Risk Adjustment in Colorectal Surgery Patients.
    Strombom P; Widmar M; Keskin M; Gennarelli RL; Lynn P; Smith JJ; Guillem JG; Paty PB; Nash GM; Weiser MR; Garcia-Aguilar J
    Ann Surg Oncol; 2019 Sep; 26(9):2797-2804. PubMed ID: 31209671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of the Charlson comorbidity index computed from routinely collected hospital discharge diagnosis codes.
    O'Connell RL; Lim LL
    Methods Inf Med; 2000 Mar; 39(1):7-11. PubMed ID: 10786063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting adverse events, length of stay, and discharge disposition following shoulder arthroplasty: a comparison of the Elixhauser Comorbidity Measure and Charlson Comorbidity Index.
    Kim CY; Sivasundaram L; LaBelle MW; Trivedi NN; Liu RW; Gillespie RJ
    J Shoulder Elbow Surg; 2018 Oct; 27(10):1748-1755. PubMed ID: 29798824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.